What Happened?
Boston, MA-based PepGen Appointed Noel Donnelly as Chief Financial Officer
About the Company
Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.
About the Person
Noel Donnelly is Chief Financial Officer at PepGen. Previously, Noel held various senior HR leadership roles in the industry.
Info Source
News
Short Profile